naltrexone has been researched along with Convulsive Generalized Seizure Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, B; Singh, SM | 1 |
| Bahremand, A; Dehpour, AR; Ghasemi, M; Gholizadeh, S; Nasrabady, SE; Shafaroodi, H | 1 |
1 review(s) available for naltrexone and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Unintentional rapid opioid detoxification: case report.
Topics: Adult; Consciousness Disorders; Critical Care; Diazepam; Drug Interactions; Emergency Service, Hospital; Epilepsy, Generalized; Humans; Illicit Drugs; Infusions, Intravenous; Male; Naltrexone; Narcotic Antagonists; Narcotics; Neurologic Examination; Opioid-Related Disorders; Private Practice; Substance Abuse Detection; Substance Withdrawal Syndrome | 2009 |
1 other study(ies) available for naltrexone and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoids; Convulsants; Dose-Response Relationship, Drug; Drug Synergism; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Injections, Intraperitoneal; Male; Mice; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Piperidines; Pyrazoles; Seizures | 2008 |